Revvity, Inc. stock is up 7.71% since 30 days ago. The next earnings date is Feb 13, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 62% of the previous 49 December’s closed higher than November. In the last 6 Unusual Options Trades, there were 4 PUTs, 2 CALLs.
|Date & Time||Expiration Date||Strike Price||Trade Type||Size||Open Interest|
|18 Oct 17:10||17 Nov, 2023||95.00||0|
|30 Oct 15:39||17 Nov, 2023||80.00||0|
|30 Oct 16:10||15 Mar, 2024||125.00||11|
|30 Oct 17:10||17 Nov, 2023||75.00||0|
|31 Oct 14:17||17 Nov, 2023||80.00||93|
|03 Nov 17:45||15 Dec, 2023||115.00||10|
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.